Donghai Jiang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 15
- Drug Transport and Resistance Mechanisms 5
- Pancreatic and Hepatic Oncology Research 3
-
- Cancer therapeutics and mechanisms 3
- Co-authors
- Lin Zhou (9 shared papers)Weimin Fan (6 shared papers)Liang Xu (3 shared papers)Danni Chen (3 shared papers)Haiyang Xie (8 shared papers)Meihua Sui (3 shared papers)Shusen Zheng (9 shared papers)Bisha Ding (3 shared papers)
- Journals
- Oncology Reports (2 papers)International Journal of Biological Sciences (2 papers)Journal of Translational Medicine (2 papers)Cancer Letters (2 papers)American Journal of Cancer Research (1 paper)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Donghai Jiang
24 papers receiving 654 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 260
- Biomaterials 109
- Molecular Biology 407
- Oncology 144
- Immunology 64
Countries citing papers authored by Donghai Jiang
This map shows the geographic impact of Donghai Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghai Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghai Jiang more than expected).
Fields of papers citing papers by Donghai Jiang
This network shows the impact of papers produced by Donghai Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghai Jiang. The network helps show where Donghai Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Donghai Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 133 | |
| 2 | 2017 | 78 | |
| 3 | 2019 | 77 | |
| 4 | 2018 | 70 | |
| 5 | 2019 | 50 | |
| 6 | 2013 | 37 | |
| 7 | 2011 | 33 | |
| 8 | 2020 | 30 | |
| 9 | 2009 | 28 | |
| 10 | 2016 | 20 | |
| 11 | Endoplasmic reticulum stress triggers delanzomib-induced apoptosis in HCC cells through the PERK/eIF2α/ATF4/CHOP pathway. | 2020 | 19 |
| 12 | Cabazitaxel, a novel chemotherapeutic alternative for drug-resistant hepatocellular carcinoma. | 2018 | 17 |
| 13 | 2014 | 15 | |
| 14 | Y-320, a novel immune-modulator, sensitizes multidrug-resistant tumors to chemotherapy. | 2020 | 9 |
| 15 | 2023 | 7 | |
| 16 | 2022 | 7 | |
| 17 | The contributions of extrachromosomal DNA elements in neoplasm progression. | 2021 | 6 |
| 18 | 2016 | 5 | |
| 19 | 2015 | 4 | |
| 20 | 2024 | 4 |
About Donghai Jiang
Donghai Jiang is a scholar working on Oncology, Molecular Biology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 24 papers that have together received 658 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Cancer-related molecular mechanisms research (4 papers), Estrogen and related hormone effects (4 papers), MicroRNA in disease regulation (3 papers), Cancer therapeutics and mechanisms (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Cancer Research (260 citations), Biomaterials (109 citations), Molecular Biology (407 citations), Oncology (144 citations) and Immunology (64 citations). Donghai Jiang has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Lin Zhou, Weimin Fan, Liang Xu, Danni Chen, Haiyang Xie, Meihua Sui, Shusen Zheng, Bisha Ding, Xiao Xu and Weimin Fan. Their work appears in journals such as Oncology Reports, International Journal of Biological Sciences, Journal of Translational Medicine, Cancer Letters and American Journal of Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.